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100% specific for the 59 strains tested. For part 2: Out of the 40 specimens,
6 MDRA were detected: 4 by all the agars, 1 picked up by Hardy alone (non-
MDRA acinetobacter by the others), 1 picked by both CHROMagar and Hardy
(non-MDRA acinetobacter by m-LAM). Upon re-examination, multiple col-
onies with different susceptibility profile were found on the agars. Discrep-
ancy was likely due to chance of picking the resistant colonies. For the 34
non-MDRA specimens, follow up tests were required in 6 when using m-
LAM, 13 when using Hardy, and 5 when using CHROMagar.
Figure. Appearances of MDRA in the three tested MDRA selective agars.
Conclusions: The three tested selective agar media have good sensitivity
and specificity for detecting MDRA. Each has its own advantage and disad-
vantage and the choice should be made by individual laboratories.PS 2-327
EPIDEMIOLOGY OF CANDIDEMIA IN A MEDICAL CENTER IN MIDDLE
TAIWAN
Hui-Lan Chang a, Li-Jhen Lin a, Ing-Moi Hii b, Chun-Eng Liu a,b. aInfection
Control Committee, Changhua Christian Hospital, Changhua, Taiwan;
bDepartment of Internal Medicine, Changhua Christian Hospital, Changhua,
Taiwan
Purpose: Opportunistic pathogens such as yeast infections caused by
Candida bacteremia (Candidemia),Clinical morbidity and mortality is still
an important reason.This experiment was collected from 2009 to 2012 in
Taiwan Medical Center clinical laboratory data were retrospective study of
patients with candidemia.
Methods: To test the disk colorimetric microdilution,Configure the appro-
priate dilution test disc antibiotics and coloring indicator,After the addition
of non-critical liquid yeast culture,In manual interpretation manner lowest
antifungal concentration observed inhibition of microbial growth, fungal
drug susceptibility testing operation,Understanding of the distribution and
drug susceptibility against fungal change clinical pathogenic yeast.
Results
Candida albicans accounted for 45.2%, Candida tropicalis 22.3%, Candida
glabrata 21.8%, Candida parapsilosis 8.5%, Candida krusei 1.1% and 1% oth-
er.Gender distinction, men 63.3%, women 36.7%.To distinguish between age
0 to 20 years old 4.3%, 5.9% from 21 to 40 years old, 41 to 60 years 19.7%
47.9% 61 to 80 years, 22.3 percent of 81 to 100 years old.In 2009 and 2012
isolates, a total of 188 cases of patients with candidemia in this study.
Conclusions: The experiments showed that the most frequently isolated re-
mains C.albicans,Others in sequence for C.tropicalis, C.glabrata, C.parapsi-
losis and C.krusei ... etc.Amphotericin B, Posaconazole drug susceptibility
testing,CLSI M27-S3 No interpretation no breakpoint therefore to represent.
Anidulafungin, Micafungin this experiment Candida spp.Are all Suscepti-
ble.C.glabrata, C.tropicalis drugs Susceptible lower. Necessary with focus
on prompt identification of patients at risk for candidemia due to resistant
strains and the effect of appropriate antifungal therapy on mortality.
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THE MANAGERIAL EXPERIENCE OF REUSE OF SINGLE-USE MEDICAL
DEVICES
Li-Jhen Lin a, Hui-Lan Chang a, Chun-Eng Liu a,b. aInfection control
Committee, Changhua Christian Hospital, Taiwan; bInformation Technology
Department, Changhua Christian Hospital, Taiwan
Purpose: To develop audit procedure and administration policy for reuse of
single-use medical devices so that the introduction of these devices intoclinical practices can be regulated to prevent increasing risk of infection
due to inappropriate reuse of these devices on patients.
Material and methodology:
1. Resource management department receives the application from the
“team for incoming new medical materials” and reminds the applicants
of clinical units to complete the application via electronic administra-
tion system with attachment of the “audit form for resuse of single-use
medical devices” approved by the IPC center.
2. The single-use medical devices can be reused only after the application
is approved by the IPC center and co-signed by the associated
committees.
3.All units stipulate the items and management policy of reusable single-
use devices.
4. The clinical units record and report defective rate and expired rate of
reusable single-use medical devices quarterly; and count the number of
reused single-use medical devices, document the identification and
tracking of exposed patients and perform testing for reusable medical
devices monthly.
5. After comparison to the data between infection control information
system and laboratory information system, the medical technologist
of IPC center inform the physicians and clinical units about suspected
cases.
6. The IPC center irregularly check the management policy of reusable
medical devices in each unit.
7. The annular check report of reused medical devices from IPC center
will be feedback to each unit
Results: Quality management index:1. The monthly associated complication
rate of reusable medical devices2. The qualified rate of reusable medical de-
vices3. The quarterly defective rate of reusable medical devices
Keywords::Reuse of single-use medical devicesPS 2-329
EFFICIENT ENVIRONMENT SURVEILLANCE CULTURE MONITORING
ACTIVITIES WITH DEVELOPING COMPUTER PROGRAM
Soon Im Choi a, Kyung Hee Lee a, Chun Soo Kim a, Nam Hee Ryoo a,c, Sung
Yeul Ryu a,b, Jin Ho Cheon d, Dong Jin Jeong c. aInfection Control Team,
Dongsan Medical Center; bDepartment of Internal Medicine, Keimyung
University, Daegu, South Korea; cLaboratory Medicine, Keimyung University,
Daegu, South Korea; dElectronic Data Center, Dongsan Medical Center
Purpose: In the field of infection control, it is important to maintain and
disinfect a clean environment as much as hand hygiene because spreading
of bacteria is mainly through polluted surface or medical instruments.
Some department conducts test for environment surveillance cultures regu-
larly. This test should be well-organized, qualified, and revised every year. In
order to manage scattered items of all departments efficiently, infection
control team is in charge of developing ‘environment surveillance culture’
computation program.
Methods:
1. The overview of Environment Surveillance Culture computation program
(1) Registration of common items for ‘environment surveillance cultures’
(2) Request and enrollment of examinations from each department
through program, without submitting cooperation document
(3) Registration to Department of Laboratory Medicine
(4) Laboratory Medicine specialists confirm the result and attach comment.
(5) The department registered items check the result.
2. Education and promotion of use of the program
3. Evaluate the necessity of test and confirm the results.
4. The important notice is uploaded to intra-office network page.
5. Establish documented method of environmental surveillance culture.
6. Through the program, it is easy to request tests, see the results, and
simplify the procedure.
Results:
1. Infection Control Team generalizes all procedures and coordinates each
department.
2. Set the test date by using program and the lab manage possible dates for
high-efficiency.
3. By posting the result of working place safety result to intra-office network
page.
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monitoring procedure is highly-efficient. Also, the establishment of stan-
dards of testing specimen can avoid contamination.
Conclusions: Most departments are highly satisfied with the program
because of increased work efficiency. In future, this program can be consid-
ered to contribute to inspect test results of epidemic outbreak and do ‘qual-
ity assurance’ of the medical practice directly related to infection control as
well as consistent monitoring will be needed.PS 2-330
EXPLORE THE BENEFIT OF IMPLEMENTATION CVBSI BUNDLES
INFORMATION SYSTEM IN A HOSPITAL
Hui-Chun Chung a,b, Hui-Li Jiang c, Qing-Xiao Lin e, Yu-Huai Ho d,
Chen-Hui Wang c, Xiu-Hui Huang a, Ya-Pin Xu c, Lih-Shinn Wang d. aHualien
Tzu Chi Hospital, Department of Nursing, Taiwan; bBuddhist Tzu Chi
University, Institute of Medical Science, Taiwan; cUnit of Infection Control
and Management, Hualien Tzu Chi Hospital, Taiwan; dDivision of infection
Diseases, Department of Internal Medicine, Hualien Tzu Chi Hospital,
Taiwan; eDepartment of MIS, Hualien Tzu Chi Hospital, Taiwan
Purpose: The purpose of this study was to establish a CVBSI Bundles Informa-
tion System which composes the idea of integrated prevent Central Line-
Associated Bloodstream Infections. And constructed a convenience for elec-
tronic documentation, data storage, benefit evaluation and a platform from
medical team member communication.
Methods: CVBSI Bundles Information System was based on the hospital infor-
mation system (HIS) and constructed into 5 pages, there could print pa-
tients’ care information out from the system and reduce duplication
writing. All the hospital ICN was in-charge central line management. Statis-
tical analysis of the system function could be used as basis for assessing the
quality of related work.
Results: Compare to last year, daily assessment and maintenance of central
lines adherence rate were increased from 48.5% to 90.9% and 22.9% to 86.4%,
Central Line-Associated Bloodstream Infection rate was decreased\ from
4.8&to 3.0&, cost down 621,720NT$.
Conclusions: CVBSI Bundles Information System did simplify the operation
and handwritten medical records, reduce the Central Line-Associated
Bloodstream infections rate and cost down.PS 2-331
THE VIRULENCE EFFECT CAUSED BY WZI GENE IN KLEBSIELLA
PNEUMONIAE
Li-Yueh Huang a, Fei-Hsu Chen b, Jen-Chang Chang a, Yu-Kuo Tsai a,
Ci-Hong Liou c, Ling Ma a, Fu-Mei Lin a, Yi-Jiun Ding a, Pei-Jing Chen a,
Jung-Chung Lin b,c, Kuo-Ming Yeh c, L. Kristopher Siu a,b,c. aInstitute of
Infectious Diseases and Vaccinology, National Health Research Institutes,
Miaoli, Taiwan; bGraduate Institute of Microbiology and Immunology,
National Defense Medical Center, Taipei, Taiwan; cDivision of Infectious
Diseases and Tropical Medicine, Department of Internal Medicine, Tri-
Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Purpose: Klebsiella pneumoniae (Kp) is a well-known pathogen and a com-
mon reason of community-acquired and nosocomial infections causing liver
abscesses, endophthalmitis, or meningitis. Capsular polysaccharide (CPS) is
one of the most important virulent factors in Kp. The virulence effect caused
by wzi gene that is involved in the attachment of the repeat unit of CPS to
outer membrane remains uncertain. Previous studies indicate that deduced
Wzi protein sequence is corresponding to capsular serotype (K-type). This
study aimed to examine the gene actual effect on virulence and its changes
associated with K-type switch.
Methods: In-frame deletion and replacement was used to obtain the dele-
tion and switched mutants of the wzi gene in Kp strain 312, which isolated
from liver abscess patient and harbored K20 CPS cluster. The wzi gene of
switched mutant was replaced from K20-type to K1-type. The virulence
was assessed through serum killing, neutrophil phagocytosis and mouse
lethality assay.
Results: Comparison to the parental 312 strain (K20, serum-sensitive, phago-
cytosis-resistant, LD50Z10
2 cfu), 312D wzi mutant decreased 102-fold ofLD50 and exhibited more susceptible in serum killing and phagocytosis.
LD50 of 312D wzi::K1-wzimutant was 10
3 cfu and there was no significant dif-
ference in virulence assay between 312D wzi and 312D wzi::K1-wzi strains.
Conclusions: The study demonstrates that wzi gene has impact in virulence
in mice model, and contributes to serum killing and phagocytosis of Kp
strains. Furthermore, replacement of distinct K-type wzi gene can also influ-
ence the mice lethality.PS 2-332
EMERGENCE OF TWO KPC NEW VARIANTS (KPC-17 AND KPC-22) IN
SOUTHERN TAIWAN: A CASE REPORT
Shu-Ching Hsu a, Wen-Liang Yu b, Mei-Feng Lee c, Yin-Ching Chuang c,d.
aInfection Control Committee, Taiwan; bDepartment of Intensive Care
Medicine, Taiwan; cDepartment of Medical research, Chi-Mei Medical
Center, Tainan, Taiwan; dDepartment of Medicine, Chi Mei Medical Center-
Liou Ying, Tainan, Taiwan
Purpose: Klebsiella pneumoniae carbapenemase (KPC) is one of the most
common carbapenemases. KPC-2-containing K. pneumoniae with sequence
type (ST) 258 and ST 11 clones have been the most worldwide spread. We
report a patient with two KPC new variants (KPC-17 and KPC-22) recovered
from a patient in a nursing home.
Case report
An 86 year-old woman had stayed in a nursing home for 5 month. She was
admitted to the hospital due to acute delirium on March 21, 2014. Brain CT
showed mild cerebral atrophy. Laboratory data showed hemogram, 10.5 g/
dL; WBC, 14,900/mL; CRP, 63.9 mg/L; and creatinine, 2.8 mg/dL. CXR
showed mild bronchiectasis with probably superimposed infection. Empirical
antibiotic was ceftazidime. The sputum culture yielded mixed normal flora.
The blood and urine cultures showed no growth. However, CRP rose to 114.0
mg/L on March 31. Fosfomycin was added. The blood and sputum cultures
showed no significant bacteria, but the urine culture yielded yeast-like
organism. A CRP rose to 135.3 mg/L on April 7. Thus doripenem and
fluconazole were used. Then condition was stable and she was discharged to
a nursing home on April 14. On June 19, 2014, she returned with a fever of
38C. Urine routine showed WBC, 50-99/HPF; leukocyte esterase 3+ and
bacilli 3+. Co-amoxiclav was used for 7 days. The urine yielded imipenem-
resistant K. pneumoniae (IRKP), only susceptible to amikacin, gentamicin,
tigecycline and co-trimoxazole. On July 9, she had a fever of 38.1C. Urine
showed pyuria and IRKP, additionally resistant to tigecycline. Co-trimoxa-
zole was used for 7 days and eradicated the IRKP. PCR for blaKPC in the
plasmid of the IRKP isolates and DNA sequencing confirmed blaKPC-17 in 1st
IRKP and a new variant blaKPC-22 (GenBank acc no. KM379100) in 2nd IRKP.
Conclusions: We report two nursing home-acquired blaKPC-17- and blaKPC-22-
harboring IRKP isolates. Clinicians should be alert to IRKP, which may be a
KPC variant.PS 2-333
FIRST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)
CASE IN SOUTHEAST ASIA (OUTSIDE MIDDLE EAST)
Z. H. Liew a, M. L. Look b. aDepartment of Renal Medicine, Singapore
General Hospital, Singapore; bDepartment of Medicine, Hospital Sultanah
Nora Ismail, Batu Pahat, Johor, Malaysia
Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused
by a coronavirus called MERS-CoV. It was first reported in Saudi Arabia in
2012 and has since spread to various Middle Eastern, European, North African
and Asian countries. In this case study, we report a 54-year-old man who
became the first laboratory-confirmed case of MERS-CoV infection in
Malaysia, as well as in Asia (outside Middle East), and also the first death
in this region due to the infection. He had underlying diabetes mellitus,
complaining of cough, fever and shortness of breath for 2 days with recent
visit to Middle East. Chest radiograph show a consolidation at the right
midzone. Blood investigations showed a normal haemoglobin and white cell
count with platelet 127 000/mm3, creatinine 132 micromol/L, urea 11
mmol/L, CK 935 mmol/L, ALT 62 mmol/L and AST 145 mmol/L. He was
started on intravenous Amoxycillin-Clavulanate acid, oral Erythromycin,
and oral Oseltamivir for pneumonia and throat swab was sent for MERS-
